Btg2 Enhances Retinoic Acid-Induced Differentiation by Modulating Histone H4 Methylation and Acetylation
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Retinoic acid controls hematopoietic differentiation through the transcription factor activity of its receptors. They act on specific target genes by recruiting protein complexes that deacetylate or acetylate histones and modify chromatin status. The regulation of this process is affected by histone methyltransferases, which can inhibit or activate transcription depending on their amino acid target. We show here that retinoic acid treatment of hematopoietic cells induces the expression of BTG2. Overexpression of this protein increases RARalpha transcriptional activity and the differentiation response to retinoic acid of myeloid leukemia cells and CD34+ hematopoietic progenitors. In the absence of retinoic acid, BTG2 is present in the RARalpha transcriptional complex, together with the arginine methyltransferase PRMT1 and Sin3A. Overexpressed BTG2 increases PRMT1 participation in the RARalpha protein complex on the RARbeta promoter, a target gene model, and enhances gene-specific histone H4 arginine methylation. Upon RA treatment Sin3A, BTG2, and PRMT1 detach from RARalpha and thereafter BGT2 and PRMT1 are driven to the cytoplasm. These events prime histone H4 demethylation and acetylation. Overall, our data show that BTG2 contributes to retinoic acid activity by favoring differentiation through a gene-specific modification of histone H4 arginine methylation and acetylation levels.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A decade of molecular biology of retinoic acid receptors
Chambon, P. (1996) · The FASEB Journal · doi:10.1096/fasebj.10.9.8801176 · Cited by 2,889 · cited 3×
“Histone acetylation contributes to modify chromatin structure and allows gene transcription (9).”
BackgroundActive Genes Are Tri-Methylated at K4 of Histone H3
Santos-Rosa, H., Schneider, R., Bannister, A. J., Sherriff, J., Bernstein, B. E., Emre, N. C. T., Schreiber, S. L., Mellor, J., & Kouzarides, T. (2002) · Nature · doi:10.1038/nature01080 · Cited by 2,138 · cited 1×
“correlates with active gene transcription (7, 41).”
Rouault, J.-P., Falette, N., Guéhenneux, F., Guillot, C., Rimokh, R., Wang, Q., Berthet, C., Moyret-Lalle, C., Savatier, P., Pain, B., et al. (1996) · Nature Genetics · doi:10.1038/ng1296-482 · Cited by 434 · cited 1×
“BTG2/ PC3/Tis21 is a PRMT1 binding protein and the product of a p53 regulated gene (1, 8, 13, 30, 40 , 52).”
BackgroundGuardavaccaro, D., Corrente, G., Covone, F., Micheli, L., D'Agnano, I., Starace, G., Caruso, M., & Tirone, F. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.5.1797-1815.2000 · Cited by 230
Self-citationDuriez, C., Falette, N., Audoynaud, C., Moyret-Lalle, C., Bensaad, K., Courtois, S., Wang, Q., Soussi, T., & Puisieux, A. (2002) · Gene · doi:10.1016/s0378-1119(01)00825-3 · Cited by 73 · cited 2×
“Nevertheless, the differentiation effect that we observed could contribute physiologically to growth limitation and provide further support to the role of tumor suppressor (14, 23, 49) hypothesized for BTG2.”
Background
Cited by
Fontana, L., Pelosi, E., Greco, P., Racanicchi, S., Testa, U., Liuzzi, F., Croce, C. M., Brunetti, E., Grignani, F., & Peschle, C. (2007) · Nature Cell Biology · doi:10.1038/ncb1613 · Cited by 384
Self-citationRetinoic acid signaling and neuronal differentiation
Janesick, A., Wu, S. C., & Blumberg, B. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1815-9 · Cited by 295
The mammalian anti‐proliferative BTG/Tob protein family
Winkler, G. S. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.21919 · Cited by 287
Tumor suppressors BTG1 and BTG2: Beyond growth control
Yuniati, L., Scheijen, B., van der Meer, L. T., & van Leeuwen, F. N. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.27407 · Cited by 229
“Moreover, BTG2 favors RA‐induced hematopoietic differentiation through regulation of gene‐specific histone methylation, by recruiting the arginine methyltransferase PRMT1 to the RA receptor complex (Passeri et al., 2006).”
BackgroundInfluentialDescalzi, G., Mitsi, V., Purushothaman, I., Gaspari, S., Avrampou, K., Loh, Y.-H. E., Shen, L., & Zachariou, V. (2017) · Science Signaling · doi:10.1126/scisignal.aaj1549 · Cited by 188
“Within the mPFC, Btg2 expression was reduced, and previous findings have shown Btg2 involvement in neurite outgrowth (106) and histone H4 arginine methylation and acetylation processes (107).”
BackgroundPhanstiel, D., Brumbaugh, J., Berggren, W. T., Conard, K., Feng, X., Levenstein, M. E., McAlister, G. C., Thomson, J. A., & Coon, J. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710515105 · Cited by 166
BTG2: A rising star of tumor suppressors (Review)
MAO, B., ZHANG, Z., & WANG, G. (2015) · International Journal of Oncology · doi:10.3892/ijo.2014.2765 · Cited by 160
“It has been demonstrated that BTG2 can arrest cells at G1/S and G2/M transition, increase apoptosis (14), promote retinoic acid-induced differentiation in hematopoietic cells (16) and inhibit expansion of thymocytes (17).”
BackgroundTirone, F., Farioli-Vecchioli, S., Micheli, L., Ceccarelli, M., & Leonardi, L. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00059 · Cited by 32
Self-citation
Metadata
- Authors
- Passeri, D., Marcucci, A., Rizzo, G., Billi, M., Panigada, M., Leonardi, L., Tirone, F., & Grignani, F.
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 2006-07-01
- Volume
- 26
- Issue
- 13
- Pages
- 5023-5032
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- OpenAlex
- W2051508016
- Cited by
- 64
- References
- 5
- FWCI
- 1.96
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.